Pfizer

Yesterday
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note Zacks18:47 16-Dec-25
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast The Motley Fool18:32 16-Dec-25
Pfizer ’26 Guidance Puts Emphasis On The Long Term For A Return To Growth Scrip Pharma Intelligence16:31 16-Dec-25
Tepid 2026 outlook dents Pfizer shares France 2416:13 16-Dec-25
Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO Yahoo! UK & Ireland15:53 16-Dec-25
Pfizer faces challenging years on fading COVID sales, margin pressure The Spokesman-Review, Washington15:52 16-Dec-25
Market movers: Circle, Pfizer, Reconnaissance Energy Africa... Proactive Investors (Canada)14:49 16-Dec-25
Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures Pharmaceutical Technology13:19 16-Dec-25
Pfizer shares drop 5% with 2026 revenue projection and long-range outlook FiercePharma12:56 16-Dec-25
Pfizer shares fall after it forecasts 2026 revenue below estimates Proactive Investors (US)12:24 16-Dec-25
Pfizer Reprices Lower as Investors Digest Slowing COVID Sales and LOE Impact Investing.com UK12:13 16-Dec-25
The Future of Leadership Is Vulnerable, Not Bossy with Selena Rezvani All Work12:03 16-Dec-25
Pfizer Drops as Drugmaker Predicts Little Sales Growth in 2026 Bloomberg Law11:47 16-Dec-25
US Stock Market Today: Wall Street mostly flat after jobs data signal softening labor market,… Mint11:24 16-Dec-25
Pfizer sees weaker 2026 due to lower Covid-19 sales London South East10:14 16-Dec-25
Kraft Heinz taps new CEO, PayPal files for US bank charter Yahoo! US09:56 16-Dec-25
Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts Benzinga09:43 16-Dec-25
Pfizer Stock (PFE) Rises despite Weaker 2026 Profit Outlook on Fading COVID-19 Franchise TipRanks08:26 16-Dec-25
Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings Yahoo! US08:14 16-Dec-25
Pfizer Revises 2025 Revenue Guidance to $62 Billion TipRanks07:36 16-Dec-25
Pfizer facing lower revenues as sales of covid vaccines fall Irish Examiner07:25 16-Dec-25
Pfizer forecasts 2026 profit below expectations on lower Covid product sales Yahoo! US07:03 16-Dec-25
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance Business Wire (Press Release)06:47 16-Dec-25
Where Will Eli Lilly Be in 10 Years? The Motley Fool05:50 16-Dec-25
In the last 7 days
Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst Benzinga13:05 15-Dec-25
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know Zacks10:09 15-Dec-25
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million Yahoo! US08:35 15-Dec-25
Pfizer’s New Phase 1 Study: A Potential Breakthrough for Kidney Disease Treatment TipRanks11:40 14-Dec-25
Forget Teladoc and Buy This Healthcare Stock Instead The Motley Fool06:55 13-Dec-25
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. The Motley Fool12:05 12-Dec-25
Pfizer Declares First-Quarter 2026 Dividend Business Wire (Press Release)12:04 12-Dec-25
The Best Turnaround Stock to Invest $1,000 in Right Now The Motley Fool11:04 12-Dec-25
Is Pfizer Shifting From Defensive Stock To Value Opportunity After Post Pandemic Restructuring? Simply Wall St10:37 12-Dec-25
Fierce Pharma Asia—Pfizer, Zealand metabolic disease deals; China's 1st private insurance… FiercePharma08:26 12-Dec-25
Flutter hires Pfizer’s exec amid new push for US prospects SBCNews06:39 12-Dec-25
RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses Medpage Today17:01 11-Dec-25
Elevance Health Adds Former Pfizer GC To Its Board Law36016:32 11-Dec-25
Hot Picks: Large-cap health care stocks to watch for dividend growth BNN Bloomberg15:33 11-Dec-25
Democratic Senators Demand Details on Trump’s Drugmaker Deals Bloomberg Law15:19 11-Dec-25
Fit for Pharmacology University of Manitoba News13:22 11-Dec-25
Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by… FiercePharma09:33 11-Dec-25
Pfizer plans job cuts in Switzerland to reduce expenses Pharmaceutical Technology09:14 11-Dec-25
A four-step way out of pharma manufacturing’s asset management struggles European Pharmaceutical Review08:42 11-Dec-25
Town Health donates Pfizer pneumococcal vaccines PCV20, as chair Karson Choi urges seniors to get vaccinated Hong Kong Standard08:12 11-Dec-25
Pfizer makes first-line case for Tukysa in breast cancer pharmaphorum07:35 11-Dec-25
Pfizer's $2bn+ obesity bet, and other weight-loss news pharmaphorum05:23 11-Dec-25
China’s Fosun Pharma strikes $2bn obesity drug deal with Pfizer China Economic Review04:20 11-Dec-25
New survey reveals how older Brits are determined to dodge winter viruses to protect their… Business Wire (Press Release)01:03 11-Dec-25
Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence deal FinanceAsia22:45 10-Dec-25
Fosun Pharma subsidiary signs potential $1.9bn Pfizer deal FinanceAsia22:32 10-Dec-25
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider Zacks18:51 10-Dec-25
Texas AG Secures $41.5M Settlement With Pfizer and Tris Pharma Over Allegedly Adulterated ADHD Drug: What Health Care… JD Supra14:07 10-Dec-25
Pfizer's Tukysa Combo Shows Strong PFS Benefit In Metastatic Breast Cancer Benzinga14:00 10-Dec-25
Pfizer to cut hundreds of jobs in Switzerland by year-end Investing.com13:30 10-Dec-25
Pfizer to cut over 200 jobs in Switzerland to reduce costs, Bloomberg News reports Yahoo! US12:13 10-Dec-25
Pfizer layoffs: Pharma giant to cut hundreds of jobs in this country to reduce costs Mint11:46 10-Dec-25
Pfizer Is Cutting Hundreds of Jobs in Switzerland to Lower Costs Bloomberg Law11:31 10-Dec-25
Pfizer's Tukysa delays HER2 breast cancer progression as 1st-line maintenance therapy FiercePharma09:17 10-Dec-25
PFE Buys Oral GLP-1 Drug From China Biotech to Boost Obesity Presence Zacks08:49 10-Dec-25
JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now? Zacks08:39 10-Dec-25
Tukysa Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over … Business Wire (Press Release)08:18 10-Dec-25
Pfizer boosts its obesity plans with $2bn GLP-1 YaoPharma deal European Pharmaceutical Review07:17 10-Dec-25
Pfizer Signs License Deal With Fosun Unit for Obesity Drug (2) Bloomberg Law05:45 10-Dec-25
Yao Pharma licenses oral GLP-1R agonists to Pfizer for $1.93 B BioSpectrum Asia03:36 10-Dec-25
Pfizer To Pay $150 Million Upfront To Fosun Pharma In New China Move Forbes02:09 10-Dec-25
In the last month
China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer South China Morning Post23:15 9-Dec-25
Pfizer Follows $10bn Metsera Purchase By Licensing YaoPharma Obesity Asset Scrip Pharma Intelligence18:00 9-Dec-25
Down 50%, Should You Buy the Dip on Pfizer? The Motley Fool16:45 9-Dec-25
Will Pfizer’s YaoPharma deal deliver a powerful new oral obesity pill? Invezz15:52 9-Dec-25
Dec. 9 Business Watch: Air Products links with Yara; OTR Therapeutics launches with Pfizer backing Chemical & Engineering News15:28 9-Dec-25
Moderna, Pfizer, and BioNTech stock briefly dips on FDA Covid vaccine probe Investing.com14:26 9-Dec-25
Pfizer gains another obesity asset with $2bn deal for YaoPharma’s GLP-1RA Pharmaceutical Technology08:36 9-Dec-25
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License… PR Newswire (Press Release)06:59 9-Dec-25
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma Business Wire (Press Release)06:32 9-Dec-25
Meds from Pfizer, Lilly, J&J and more secure spots in China's 1st private insurance formulary FiercePharma16:56 8-Dec-25
"Migraine Matters: Bridging the Care Gap" Wins Silver Davey Award for Excellence in Health… PRWeb (Press Release)16:12 8-Dec-25
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs Morningstar11:47 8-Dec-25
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients PMLiVE08:03 8-Dec-25
ASH: Regeneron makes frontline case for Lynozyfic in myeloma pharmaphorum07:02 8-Dec-25
Quant Small Cap Fund increases stake in Nbcc, Pfizer and 13 other stocks, trim exposure in 3 stocks in November The Economic Times05:37 8-Dec-25
LLY, PFE: Eli Lilly’s Mounjaro, Pfizer’s Cancer Drug Added to China’s State Insurance List TipRanks02:40 8-Dec-25
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025 CBS News11:51 7-Dec-25
Eli Lilly, Pfizer land on China’s first private insurance list The Hindu Business Line00:54 7-Dec-25
Hympavzi® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and… Business Wire (Press Release)17:24 6-Dec-25
ASH: Pfizer, aiming to level the hemophilia playing field, trots out new Hympavzi data FiercePharma16:04 6-Dec-25
Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue 24/7 Wall St.08:59 6-Dec-25
Do These 3 Healthcare Stocks Need a Checkup? The Motley Fool16:28 5-Dec-25
Sandoz, Pfizer Denied Bid to End Generic Drug Price-Fixing Case Bloomberg Law11:49 5-Dec-25
2 Headwinds Facing Pfizer Stock Going Into 2026 The Motley Fool10:22 5-Dec-25
DOJ tries to shut down Pfizer clinical trial whistleblower after FDA admits COVID vax killed kids Just The News23:02 4-Dec-25
OTR Therapeutics Raises $100 Million in Series A Financing to Advance Early Innovation into… PR Newswire (Press Release)20:01 4-Dec-25
A High Desert City Finds Innovative Solutions to Homelessness Direct Relief (Press Release)18:45 4-Dec-25
Pfizer, GSK, Shionogi sponsor London run of musical about antimicrobial resistance FiercePharma13:21 4-Dec-25
A Birth Control Battle: Survivors Take Pfizer to Court Over Depo-Provera Feminist Majority Foundation13:09 4-Dec-25
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos… Business Wire (Press Release)11:33 4-Dec-25
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery Zacks10:39 4-Dec-25
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (December 2025) 24/7 Wall St.08:08 4-Dec-25
Appeals court turns Enhertu patent dispute on its head pharmaphorum07:57 3-Dec-25
Elizabeth Holmes, Theranos fraudster, claims damning evidence against her was ‘false claim' Lexington Herald-Leader, Kentucky22:53 2-Dec-25
Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure Zacks11:34 2-Dec-25
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock Zacks10:03 2-Dec-25
Pfizer reported an ATTR sales decline in the US. Should newer market entrants Alnylam and… FiercePharma08:29 2-Dec-25
2 Top Dividend Stocks to Buy Now and Hold For a Decade The Motley Fool08:10 2-Dec-25
Trump Administration Unveils Details On Most-Favored Nation Prices For Drugs Forbes12:02 1-Dec-25
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with… Business Wire (Press Release)10:02 1-Dec-25
EMA starts review of 'transformative' bladder cancer therapy pharmaphorum09:19 1-Dec-25
This 7% Yielder Could Be a Top AI Play The Motley Fool16:28 30-Nov-25
Pfizer buries data showing mRNA flu vaccine bombed in trial with elderly, not much better under 65 Just The News23:01 29-Nov-25
Is Pfizer Stock Underperforming the Dow? Barchart02:47 28-Nov-25
Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet? Zacks12:56 27-Nov-25
Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings Benzinga12:46 26-Nov-25
AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights Zacks11:49 26-Nov-25
Is mRNA The Future Of Flu Shots? New Vaccine 34.5 Percent More Effective Than Standard Shots In Trials IFLScience06:50 26-Nov-25
Did Pfizer Just Say "Checkmate" to Novo Nordisk? The Motley Fool05:03 26-Nov-25
Pfizer is hard to find at Ontario pharmacies, and drugstores are complaining. Here’s what is… Toronto Star18:50 25-Nov-25

      
            
      
    view more headlines
   
      
      
      
16 Dec 18:47
   
Pfizer News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Pfizer news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Pfizer

Pfizer News

Pharmaceuticals Top Stories

Business Top Stories
